← Eichor
Study identifier: NCT06792383 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Psychological and Psychiatric Assessment in Patients Eligible for Epilepsy Surgery

Condition: Focal Epilepsy With and Without Secondary Generalization  ·  Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

PhaseNA
Planned participants180
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The aim of the study is to describe the socio-demographic, clinical, psychological, and psychiatric characteristics of patients with drug-resistant focal epilepsy eligible for epilepsy surgery and any changes in these parameters over time after surgery. Additionally, the study seeks to describe the levels of quality of life, dissociative experiences, prevalence of various psychiatric symptoms, irritability, depressive symptoms, anxiety symptoms, and stigma perception in patients with drug-resistant focal epilepsy eligible for epilepsy surgery and any changes over time after surgery.

This description comes directly from the study's public registry record.

Talk to the study team

Rui Quintas, PsyD  ·  +39 02 2394  ·  rui.quintas@istituto-besta.it

Marco de Curtis, MD  ·  +39 02 2394  ·  rui.quintas@istituto-besta.it

Always discuss trial participation with your own doctor first.

Locations (1)

Foundation IRCCS Carlo Besta Neurological InstituteMilan, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06792383